Strimvelis, the gene therapy rejected by the pharmaceutical industry that has saved Aitana
Briefly

Aitana was diagnosed with a rare genetic disease, ADA-SCID, forcing her into isolation for six months, but innovative gene therapy ultimately saved her life.
Strimvelis, the gene therapy that cured Aitana, faced potential discontinuation due to poor commercial prospects, highlighting the need for sustainable production of effective treatments.
Read at english.elpais.com
[
|
]